Pfizer and IBM announce remote monitoring solutions partnership

Pfizer and IBM announced today a novel research partnership that will lead to the development of groundbreaking remote monitoring solutions focused on revolutionizing the care Parkinson’s patients receive.

The experimental treatment will use sensors, mobile devices and machine diagnostics that will deliver live information on disease symptoms to physicians and researchers around the clock. The primary goal of the collaboration is to gain a better understanding of the disease’s progression within patients and the required medication responses. This will help provide information for decisions on treatment and the design of clinical trials, while also expediting the development of new therapeutic options.

The progression of Parkinson’s disease has led to constant adjustments when it comes to applying medications. The partnership between Pfizer and IBM is seeking a complete, holistic view of the patient’s health by developing ways to measure a variety of health indicators with more accuracy. The data could then be used to help physicians better understand the effects of the medications during the progression of the disease. This would help health care providers enhance treatment programs for the patients.